These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20854078)

  • 1. Detection of human cytomegalovirus IgG antibody using automated immunoassay with recombinant antigens gives uniform results to established assays using whole virus antigens.
    Baalawi F; Robertson P; Rawlinson WD
    Pathology; 2010; 42(6):578-80. PubMed ID: 20854078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
    Beqaj SH; Lerner AM; Fitzgerald JT
    J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
    Busse C; Strubel A; Schnitzler P
    J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
    Zhang C; Pass RF
    Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
    Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
    J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.
    Zhang C; Buchanan H; Andrews W; Evans A; Pass RF
    J Clin Virol; 2006 Mar; 35(3):338-42. PubMed ID: 16388984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection.
    Weber B; Berger A; Rabenau H
    J Virol Methods; 2001 Aug; 96(2):157-70. PubMed ID: 11445146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
    Eggers M; Radsak K; Enders G; Reschke M
    J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
    Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
    Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
    Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
    Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
    Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.